HEALTHEQUITY (HQY)

7/5/2025 22:18:02 UTC $102.16
Next Expected Report Date: 9/2/2025
Zacks Rank:

Buy

2
 
 
 
 
 
Style Scores:   Value: C Growth: B Momentum: D VGM: C

Zacks Indicator*

20
Ranked: 20 out of 99
Zacks Rank & Indicator
Agreement: F1 Estimate Revisions(#Up-#Dn 4 Wks)0
Magnitude: F1 Consensus Estimate Trend(12 Week Rev)9.19%
Upside: F1 Zacks Consensus vs Most Accurate0.00%
Last EPS Surprise0.84
Value ScoreC
P/E (F1)32.74
P/E (F1) Rel to Industry14.38
PEG Ratio1.57
P/S (F1)6.80
P/S (TTM)7.11
P/CFO29.80
P/CFO Rel to Industry32.45
EV/EBITDA Annual28.15
Growth ScoreB
Proj. EPS Growth(F1/F0)34.38%
Hist. EPS Growth(Q0/Q-1)12.34%
Qtr CFO Growth-18.56%
2 Yr CFO Growth28,297.22%
Return on Equity (ROE)11.01%
(NI - CFO) / Total Assets-5.11%
Asset Turnover0.36
Momentum ScoreD
1 Week Volume Change-23.79%
1 Week Price Chg Rel to Industry-2.44%
(F1) EPS Est 1 Week Change0.00%
(F1) EPS Est 4 Week Change-1.58%
(F1) EPS Est 12 Week Change9.19%
(Q1) EPS Est 1 Week Change0.87%

Earning Quality Score

1
Ranked: 1 out of 10
Earning Score
EPS Increases: 5 Years3
Growth Increases: 3 Years1
Breakout: SUE using Actuals1.30

Earning & Dividend Quality Score

3
Ranked: 3 out of 10
Earning & Dividend Score
R2 EPS: 10 Year0.63
R2 Dividend: 10 Year0.00
Dividend Increases: 5 Years0

Price Response Indicator

B
Ranked: B out of E
Price Response Indicator
Surprise %:35.48%
Price Response: 5 Days Prior3.84%
Price Response: 5 Days After3.33%
Last EPS Report Date6/3/2025

Zacks Insider Rank

6
Ranked: 6 out of 6
Zacks Insider Rank
Insider Held %:1.50%
# of Buyers: 12 Weeks0
# of Sellers: 12 Weeks2
% Chg in shares of insiders trading: 12 Weeks-28.41%
Quality Score
Cash Flow Earnings Growth22.57%
Cash Flow Earnings Greater Than Accrued EarningsYes
ROE Increases: 3 Years3.00
ROA Increases: 3 Years3.00
Cash Flow Increases: 3 Years3.00

* Zacks Rank = 1 when Indicator <= 5, ZR = 2 when Indicator 5 < I <= 20, ZR = 3 when Indicator 20 < I <= 79, ZR = 4 when Indicator 79 < I <= 94, ZR = 5 when Indicator 94 < I <= 99